CC BY 4.0 · Indian Journal of Neurosurgery 2023; 12(02): 168-173
DOI: 10.1055/s-0043-1771213
Original Article

Polymorphism of XRCC7 Gene and Risk of Glioma: A Prospective Case–Control Study

Deepak Choudhary
1   Department of Neurosurgery, Govind Ballabh Pant Institute of Postgraduate Medical Education & Research, New Delhi, India
,
2   Department of Biochemistry, Govind Ballabh Pant Institute of Postgraduate Medical Education & Research , New Delhi, India
,
Mamta Sumi
2   Department of Biochemistry, Govind Ballabh Pant Institute of Postgraduate Medical Education & Research , New Delhi, India
,
Binita Dholakia
1   Department of Neurosurgery, Govind Ballabh Pant Institute of Postgraduate Medical Education & Research, New Delhi, India
,
Sumit Bhandari
1   Department of Neurosurgery, Govind Ballabh Pant Institute of Postgraduate Medical Education & Research, New Delhi, India
,
Niraj Ghimire
1   Department of Neurosurgery, Govind Ballabh Pant Institute of Postgraduate Medical Education & Research, New Delhi, India
,
Sundeep Saluja
3   Department of GI Surgery, Govind Ballabh Pant Institute of Postgraduate Medical Education & Research, New Delhi, India
,
Shaam Bodeliwala
1   Department of Neurosurgery, Govind Ballabh Pant Institute of Postgraduate Medical Education & Research, New Delhi, India
,
1   Department of Neurosurgery, Govind Ballabh Pant Institute of Postgraduate Medical Education & Research, New Delhi, India
,
Anita Jagetia
1   Department of Neurosurgery, Govind Ballabh Pant Institute of Postgraduate Medical Education & Research, New Delhi, India
› Author Affiliations

Abstract

Objective The aim of this study is to determine association between polymorphism of XRCC7 gene and glioma.

Materials and Methods A case–control study was designed to analyze the prevalence of the various XRCC7 genotypes in 30 cases of histologically proven glioma and 30 age- and sex matched controls.

Result There is significantly higher prevalence of the GT and the TT genotypes of XRCC7 gene in cases of glioma as compared with control. The prevalence was significantly pronounced in two subgroups–middle aged and male gender. The presence of the XRCC7 GT or TT genotype conferred a significantly higher risk of developing glioma (odds ratio: 13.021,2.114–80.213).

Conclusion The presence of the T allele in XRCC7 polymorphism may increase the susceptibility to glioma.



Publication History

Article published online:
11 August 2023

© 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 Ruttan CC, Glickman BW. Coding variants in human double-strand break DNA repair genes. Mutat Res 2002; 509 (1-2): 175-200
  • 2 Wang LE, Bondy ML, Shen H. et al. Polymorphisms of DNA repair genes and risk of glioma. Cancer Res 2004; 64 (16) 5560-5563
  • 3 Zhao P, Zou P, Zhao L. et al. Genetic polymorphisms of DNA double-strand break repair pathway genes and glioma susceptibility. BMC Cancer 2013; 13: 234
  • 4 Adel Fahmideh M, Schwartzbaum J, Frumento P, Feychting M. Association between DNA repair gene polymorphisms and risk of glioma: a systematic review and meta-analysis. Neuro-oncol 2014; 16 (06) 807-814
  • 5 Owens M-R, Nguyen S, Karsy M. Utility of administrative databases and big data on understanding glioma treatment—A systematic review. Ind J Neurosurg 2022; 11 (02) 104-117
  • 6 Bondy ML, Wang LE, El-Zein R. et al. γ-radiation sensitivity and risk of glioma. J Natl Cancer Inst 2001; 93 (20) 1553-1557
  • 7 Kirchgessner CU, Tosto LM, Biedermann KA. et al. Complementation of the radiosensitive phenotype in severe combined immunodeficient mice by human chromosome 8. Cancer Res 1993; 53 (24) 6011-6016
  • 8 Sipley JD, Menninger JC, Hartley KO, Ward DC, Jackson SP, Anderson CW. Gene for the catalytic subunit of the human DNA-activated protein kinase maps to the site of the XRCC7 gene on chromosome 8. Proc Natl Acad Sci U S A 1995; 92 (16) 7515-7519